FLSM

Frazier Life Sciences Management Portfolio holdings

AUM $3.72B
1-Year Est. Return 129.71%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+129.71%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.5B
AUM Growth
-$170M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
55
New
Increased
Reduced
Closed

Top Buys

1
+$57.8M
2
+$27M
3
+$25.5M
4
BBIO icon
BridgeBio Pharma
BBIO
+$20.9M
5
ANTX icon
AN2 Therapeutics
ANTX
+$15.7M

Top Sells

1
+$167M
2
+$58.8M
3
+$15.2M
4
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
+$10.2M
5
ACAD icon
Acadia Pharmaceuticals
ACAD
+$6.15M

Sector Composition

1 Healthcare 99.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
26
$14.3M 0.95%
1,050,483
+219,500
27
$14.2M 0.94%
1,028,013
28
$13.7M 0.91%
+464,937
29
$13.1M 0.87%
630,897
-226,441
30
$13M 0.86%
2,142,855
31
$8.73M 0.58%
3,746,857
32
$8.71M 0.58%
600,000
-3,108,838
33
$8.66M 0.58%
881,173
34
$8.58M 0.57%
393,000
35
$8.52M 0.57%
+400,000
36
$8.4M 0.56%
1,803,204
37
$7.23M 0.48%
+292,002
38
$6.62M 0.44%
386,762
39
$6.44M 0.43%
203,684
40
$6.17M 0.41%
127,900
41
$6.05M 0.4%
2,248,194
42
$5.6M 0.37%
285,331
43
$5.2M 0.35%
85,495
44
$4.86M 0.32%
849,022
+100,000
45
$4.71M 0.31%
370,000
46
$2.71M 0.18%
78,000
47
$2.46M 0.16%
1,430,878
-970,836
48
$1.81M 0.12%
264,377
49
$1.48M 0.1%
1,647,030
50
$1.16M 0.08%
87,911
-4,589
1
2
3